Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran) and Photrexa® (riboflavin 5’-phosphate) – New indication
July 19, 2016 – Avedro announced the FDA approval of Photrexa Viscous (riboflavin 5’-phosphate in 20% dextran) and Photrexa (riboflavin 5’-phosphate) for ophthalmic use with the KXL® System in corneal collagen cross-linking (CXL) for the treatment of corneal ectasia following refractive surgery.
Top